Washington University Institute of Clinical and Translational Sciences
Washington University Institute of Clinical and Translational Sciences
批准号:
10827727
负责人:
William G. Powderly
金额:
$23.33万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-05-01 至 2024-02-29
关键词:
AccelerationAreaArtificial IntelligenceBioinformaticsBiologicalBiometryCapitalClinical SciencesCloud ComputingCloud ServiceCollaborationsCommunitiesCommunity HealthComplexComputer HardwareCost AnalysisCost SavingsDataData Storage and RetrievalDedicationsEcosystemEnvironmentFacultyFundingGenomeGoalsHealthHigh Performance ComputingHuman Genome ProjectHuman ResourcesHybridsImageIndividualInformaticsInformation TechnologyInstitutionInvestmentsLongevityMachine LearningMemoryMentorsOccupationsOutcomeOwnershipPerformancePopulation HeterogeneityPositioning AttributePrivatizationProcessQualifyingRecording of previous eventsResearchResearch InfrastructureResearch PersonnelResourcesRiskRunningScienceSeriesServicesTestingTimeTranslatingTranslational ResearchUnited States National Institutes of HealthUniversitiesVendorWashingtonWorkWorkloadcloud basedcloud platformcluster computingcomputing resourcescostcost effectivecost estimatedata centersdesigndigitaldiverse dataexamination questionsexperiencefield studyflexibilityimplementation designimprovedinnovationinteroperabilitymedical schoolsmigrationmultidisciplinarynovelnovel strategiesparent grantprogramssimulationsuccesstranslational impact
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
The Institute of Clinical and Translational Sciences aligns with the CTSA goals of developing novel solutions to
improve the efficiency, quality, and impact of translational science.
The parent grant pursues five aims:
Aim 1: Advance interdisciplinary programs to develop, promote, mentor, and retain highly qualified and
diverse faculty, trainees, and staff who translate scientific discoveries into action, thereby becoming
agents for change in their institutions and communities.
Aim 2: Facilitate research designed for implementation by engaging diverse communities and
stakeholders in multidisciplinary collaborative teams at all stages of the translational research process,
thereby demonstrating the benefit and impact of translational science.
Aim 3: Integrate research across individual lifespans and apply translational science in complex and
diverse populations to improve individual and community health through meaningful research
collaborations and sustainable partnerships.
Aim 4: Drive innovation, quality, efficiency, and inclusion in translational research to enhance
collaborations and catalyze the implementation of discovery science.
Aim 5: Apply innovative informatics and biostatistics solutions to improve quality and efficiency at every
stage of translational research, and create an ecosystem that integrates diverse data and facilitates the
interoperability, use, and reuse of digital assets.
This supplement will focus on the following aims:
Aim 1: Deploy a hybrid-cloud HPC cluster to the public cloud that is seamlessly integrated with on-
premises worker nodes and data storage.
Aim 2: Run tests on a range of HPC workloads, including Data Simulations, Bioinformatics, Artificial
Intelligence/Machine Learning & Imaging (GPU accelerator-focused), and general interactive
workloads. We will compare the performance of workloads running on cloud and on-premises nodes,
utilizing job run time and cost as the primary metrics.
Aim 3: Evaluate the viability of deploying HPC clusters and nodes to the public cloud. We will complete
this by examining the cost of running the workloads described in Aim 2 and comparing them to the
projected costs of traditional on-premises approaches.
The expected outcome of the supplement work is a comprehensive understanding to determine either what
kinds of HPC workloads are more cost effective, or more performant in a hybrid-cloud HPC environment than a
traditional on-premises deployment.
期刊论文(364)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1161/jaha.121.022513
发表时间:
2021-11-16
期刊:
Journal of the American Heart Association
影响因子:
5.4
作者:
[Javaid A, Mitchell JD, Villines TC]
通讯作者:
Villines TC
DOI:
10.1093/ofid/ofab152
发表时间:
2021-06
期刊:
Open forum infectious diseases
影响因子:
4.2
作者:
[Prusaczyk B]
通讯作者:
Prusaczyk B
DOI:
10.1111/jth.15743
发表时间:
2022-07
期刊:
Journal of thrombosis and haemostasis : JTH
影响因子:
--
作者:
[]
通讯作者:
DOI:
10.1080/07420528.2021.1871914
发表时间:
2021-05
期刊:
Chronobiology international
影响因子:
2.8
作者:
[Wu HS, Davis JE, Chen L]
通讯作者:
Chen L
DOI:
10.1097/spv.0000000000000790
发表时间:
2021-01-01
期刊:
Female pelvic medicine & reconstructive surgery
影响因子:
1.6
作者:
[Meister MR, Wang C, Lowder JL, Mysorekar IU]
通讯作者:
Mysorekar IU
共 281 条
Washington University Institute of Clinical and Translational Sciences
-
批准号:10700256
-
项目类别:
-
资助金额:$5.4万
-
财政年份:2022
-
负责人:William G. Powderly
-
依托单位:
WASHINGTON UNIVERSITY INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCES
-
批准号:10321102
-
项目类别:
-
资助金额:$6.77万
-
财政年份:2017
-
负责人:William G. Powderly
-
依托单位:
Washington University Institute of Clinical and Translational Sciences
-
批准号:10556449
-
项目类别:
-
资助金额:$1016.11万
-
财政年份:2017
-
负责人:William G. Powderly
-
依托单位:
Washington University Institute of Clinical Translational Sciences
-
批准号:9889200
-
项目类别:
-
资助金额:$935.96万
-
财政年份:2017
-
负责人:William G. Powderly
-
依托单位:
Washington University Institute of Clinical and Translational Sciences
-
批准号:10598597
-
项目类别:
-
资助金额:$1017.84万
-
财政年份:2017
-
负责人:William G. Powderly
-
依托单位:
WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCES
-
批准号:10217859
-
项目类别:
-
资助金额:$33.96万
-
财政年份:2017
-
负责人:William G. Powderly
-
依托单位:
Rosiglitazone & Exercise Training: Effects on HIV-Infected People
-
批准号:6971952
-
项目类别:
-
资助金额:$5.84万
-
财政年份:2004
-
负责人:William G. Powderly
-
依托单位:
STUDY OF ONCE-WEEKLY ALENDRONATE IN HIV-INFECTED SUBJECTS
-
批准号:6971984
-
项目类别:
-
资助金额:$0.52万
-
财政年份:2004
-
负责人:William G. Powderly
-
依托单位:
WU 122: EVALUATE METABOLIC EFFECTS OF DISCONTINUATION OF ANTIRETROVIRAL THERAPY
-
批准号:6971971
-
项目类别:
-
资助金额:$0.59万
-
财政年份:2004
-
负责人:William G. Powderly
-
依托单位:
CORE--CLINICAL FACILITY
-
批准号:6649912
-
项目类别:
-
资助金额:$28.97万
-
财政年份:2002
-
负责人:William G. Powderly
-
依托单位:
CORE--CLINICAL FACILITY
-
批准号:6492757
-
项目类别:
-
资助金额:$28.97万
-
财政年份:2001
-
负责人:William G. Powderly
-
依托单位:
PATIENT RECRUITMENT & CLINICAL MANAGEMENT CORE
-
批准号:6382005
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2000
-
负责人:William G. Powderly
-
依托单位:
CORE--CLINICAL FACILITY
-
批准号:6340653
-
项目类别:
-
资助金额:$11.18万
-
财政年份:2000
-
负责人:William G. Powderly
-
依托单位:
PATIENT RECRUITMENT & CLINICAL MANAGEMENT CORE
-
批准号:6215534
-
项目类别:
-
资助金额:$23.16万
-
财政年份:2000
-
负责人:William G. Powderly
-
依托单位:
PATIENT RECRUITMENT & CLINICAL MANAGEMENT CORE
-
批准号:6524489
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2000
-
负责人:William G. Powderly
-
依托单位:
PATIENT RECRUITMENT & CLINICAL MANAGEMENT CORE
-
批准号:6644769
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2000
-
负责人:William G. Powderly
-
依托单位:
OUTCOMES COMMITTEE AGENDA
-
批准号:6099219
-
项目类别:
-
资助金额:$19.46万
-
财政年份:1999
-
负责人:William G. Powderly
-
依托单位:
OUTREACH AGENDA
-
批准号:6099220
-
项目类别:
-
资助金额:$19.46万
-
财政年份:1999
-
负责人:William G. Powderly
-
依托单位:
CORE--CLINICAL FACILITY
-
批准号:6201154
-
项目类别:
-
资助金额:$11.18万
-
财政年份:1999
-
负责人:William G. Powderly
-
依托单位:
HIV DISEASE RESEARCH AGENDA
-
批准号:6099213
-
项目类别:
-
资助金额:$19.46万
-
财政年份:1999
-
负责人:William G. Powderly
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: